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Background: Flavonoid-rich aqueous fraction of methanolic extract of Hibiscus sabdariffa calyx was evaluated for its
anti-hepatotoxic activities in streptozotocin-induced diabetic Wistar rats.
Methods: Diabetes Mellitus was induced in Wistar rats by a single i.p injection of 80 mg/kg b.w. streptozotocin
(STZ) dissolved in 0.1 M citrate buffer (pH 6.3).
Results: The ameliorative effects of the extract on STZ-diabetes induced liver damage was evident from the
histopathological analysis and the biochemical parameters evaluated in the serum and liver homogenates.
Reduced levels of glutathione (GSH), catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase
(GPx) (3.76 ± 0.38 μM, 0.42 ± 0.04 U/L, 41.08 ± 3.04 U/ml, 0.82 ± 0.04 U/L respectively) in the liver of diabetic rats
were restored to a near normal level in the Hibiscus sabdariffa -treated rats (6.87 ± 0.51 μM, 0.72 ± 0.06 U/L,
87.92 ± 5.26 U/ml, 1.37 ± 0.06 U/L respectively). Elevated levels of aspartate amino transferase (AST), alanine amino
transferase (ALT) and alkaline phosphatase (ALP) in the serum of diabetic rats were also restored in Hibiscus
sabdariffa -treated rats. Examination of stained liver sections revealed hepatic fibrosis and excessive glycogen
deposition in the diabetic rats. These pathological changes were ameliorated in the extract-treated rats.
Conclusion: The anti-hepatotoxic activity of Hibiscus sabdariffa extract in STZ diabetic rats could be partly
related to its antioxidant activity and the presence of flavonnoids.
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The liver plays a central and crucial role in the regula-
tion of carbohydrate metabolism. Its normal function-
ing is essential for the maintenance of blood glucose
levels and of a continued supply to organs that require
a glucose energy source [1]. In addition, it has great
capacity to detoxify toxic substances and synthesize
useful ones. Therefore, the damage which is caused by
hepatotoxic agents is of grave consequence to the body
as it deprives the liver of its principal functions [2]. A
significant amount of liver damage is induced by lipid
peroxidation and other oxidative damages which are
caused by the hepatotoxic chemicals [3,4]. It has been* Correspondence: waledavade@yahoo.com
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unless otherwise stated.reported that liver injury caused by a variety of dele-
terious agents induces inflammation, necrosis, fibrosis
cirrhosis and functional deteriorations [5].
Diabetes is a chronic disease with a relatively high
prevalence in many populations across the world [6].
Diabetes is associated with several structural and
functional liver abnormalities that affect glycogen and
lipid metabolism [7-9]. Excess glycogen deposition,
fibrosis, cirrhosis, steatohepatitis and Biliary disease
in the liver has been reported in 55 – 80% of diabetic
patients [10].
Plants used in traditional medicine for the treatment
of liver disorders are of great interest, as they may serve
as potential sources for new therapeutic agents that
could be applied in the management and prevention of
hepatic injuries. For example, plants rich in different
phytochemical derivatives such as triterpenes, flavonoidsal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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patotoxic effects in experimental liver-injury models
induced by different types of hepatotoxicants, such as
carbon tetrachloride, cadmium, galactosamine, acet-
aminophen and thioacetamide [11,12].
Hibiscus sabdariffa (HS) (family: Malvaceae) has been
reported as an ethnomedicinal remedy for a variety
of ailments including hypertension, hyperlipidaemia,
obesity, diabetes, Jaundice liver and urinary problems
[13]. It’s antihypertensive [14,15] hypolipidaemic [16,17]
anti-obesity [18,19] and anti-hyperglycemic [13,17] effects
have been confirmed in man and experimental animals
and the possible mechanisms have also been delineated.
Water-soluble extracts from Hibiscus sabdariffa L. contain
several antioxidants, such as protocatechuic acid [20]
and anthocyanins [21,22]. Recent studies have shown
the potentials of these antioxidants in the protection of
liver in chemically-induced peroxidative liver damage
[22-24]. Hence this study investigates the potential anti-
hepatotoxic properties of the flavonoid-rich extract of
Hibiscus sabdariffa in animal model of streptozotocin
diabetes- induced liver damage.
Methods
Chemicals
All chemicals used were of analytical grade. STZ was
purchased from Sigma-Aldrich (St. Louis, MO, USA)
Biochemical kits for AST, ALT and ALP assay were
purchased from Randox laboratory (Crumlin, Co. Antrim,
UK); Biochemical kits for catalase, GSH, GPx and TBARS
assay were purchased from Bio Assay System (Hayward,
CA 94545 USA) while kit for SOD assay was purchased
from Cell technology Inc (Mountain View, CA 94043).
Other histological reagents and stains were purchased
from Sigma-Aldrich (St. Louis, MO, USA).
Animals
Healthy Wistar rats (200 – 250 g) of either sex obtained
from the animal holding facility of the College of Healthy
Sciences, Obafemi Awolowo University Ile-Ife were used
for the experiment. They were maintained under standard
environmental conditions of temperature, humidity and
light and fed on standard rat pellets (Ladokun feeds,
Ibadan, Nigeria) and water ad libitum. The animals were
acclimatized to the laboratory for four weeks prior to the
start of the experiment. The rats received humane care
according to the USA’s National Institute of Health’s
Guide for the Care and Use of Laboratory Animals [25]
and their experimental use was approved by the animal
Ethics Committee of Obafemi Awolowo University Ile Ife.
Experimental design
The animals were randomly assigned into five groups A,
B, C, D and E of twelve rats each. Group A was normalcontrol (normoglycemic rats), group B was test group I
(normoglycemic rats treated with Hibiscus sabdariffa
calyx extract (HSCE)); group C was diabetic negative
control (untreated diabetic rats given STZ as described
in “Induction of Experimental Diabetes” section); group
D was test group II (diabetic rats treated with HSCE);
while group E was diabetic positive control (diabetic rats
treated with protamin zinc insulin).
Plant material
Matured calyxes of H. sabdariffa obtained from a local
market in Ile-Ife, Nigeria were authenticated at the
Forestry Research Institute of Nigeria (FRIN), Ibadan
and a voucher specimen (FHI 107622) was submitted
to the FRIN Herbarium for future reference.
Extraction
Dried and pulverized calyxes of H. sabdariffa (200 g)
were extracted three times with 70% methanol (500
mls × 3) with continuous stirring at room temperature
for 24 hours each. The extract was concentrated in
vacuo at 25°C using a vacuum rotary evaporator (RE
100B, Bibby Sterilin, United Kingdom) and the aqueous
phase was partitioned with ethyl acetate (EtOAc). The
aqueous fraction (coded HSCE) was freeze dried using a
vacuum freeze drier (FT33- Armfield, England) and used
for the experiment. Solvent elimination under reduced
pressure and subsequent freeze-drying gave 11.75 g (i. e.,
5.875% yield) of a dark red, powdery extract.
Phytochemical analysis
The following phytochemical analysis was carried out on
leaves of Hibiscus sabdariffa using the procedure of [26]
as outlined below:
Test for flavonoids
0.5 g of plant sample was suspended in 5 ml of water
and 2.5 ml of methanol was added to it and filtered.
1 ml of NaOH 10% was added to 1 ml of the filtrate.
The presence of a yellow precipitate indicated the pres-
ence of flavonoids.
Test for tannins
7.5 ml of water was added to plant extract (1 g) and
heated in a water bath. It was then filtered upon cooling.
Few drops of iron III chloride (FeCl3) 0.5% were added
to 2 ml of the filtrate. The appearance of a green or
dark-blue precipitate indicated the presence of tannins.
Test for alkaloids
2 g of plant sample was heated in a test tube containing
25 ml of HCl (1%) for 15 min in a boiling water bath.
The suspension was then filtered and 5 drops of Meyer's
reagent (potassium tetra iodomecurate) were added into
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the presence of alkaloids.
Test for saponins
0.5 g of plant extract was introduced into a test tube
containing 7.5 ml of distilled water and the mixture
heated for 5 min in a boiling water bath. The solution
was then filtered and cooled to room temperature. Five
millilitres of the filtrate was introduced into a test tube
and agitated for 10 s. The formation of persistent foam
indicated the presence of saponins.
Test for triterpenes and steroids
0.5 g of plant sample was dissolved in chloroform (3 ml)
and a few drops of acetic anhydride and concentrated
H2SO4 were added. A purple coloration indicated the
presence of triterpenes while bluish-green coloration
indicated the presence of steroids. The formation of two
layers upon addition of H2SO4 is characteristic of the
presence of both triterpenes and steroids.
Test for coumarins
One milligram of moistened sample was placed in a test
tube and the test tube was covered with a filter paper
moistened with 10% NaOH solution. After exposition of
the paper to UV light for a few minutes, yellow green
fluorescence was indicative of the presence of coumarins
Acute toxicity study
Rats fasted for 16 h were randomly divided into seven
groups of five rats each. One group served as control
and received 0.3 mls of distilled water orally. The other
groups (test groups) were treated with graded doses of
HSCE; 200, 400, 800, 1600, 3200 and 6400 mg kg−1
dissolved in distilled water orally. Signs of toxicity
(convulsion, hypoactivity, weakness, ataxia and salivation)
and mortality in each cage were assessed 24 hours,
48 hours and 72 hours after administration of extract.
LD50 of HSCE was determined in the rats using method
of Abdel-Barry et al. [27].
Induction of experimental diabetes
Animals were fasted (but still allowed access to water)
for 16 hours prior to induction. Diabetes mellitus was
induced in groups C,D and E rats by a single i.p. injection
of 80 mg/kg bw STZ dissolved in 0.1 M sodium citrate
buffer (pH 6.3) as previously reported [28,29]. Group A
rats were injected with equivalent volumes of citrate
buffer i.p.
Administration of drugs
Four weeks post induction of diabetes, daily doses of
1750 mg/kg bw HSCE was administered orally to the
rats in test groups I and II (groups B and D) for 15 daysby gavage while 1 IU/kg/day of protamine zinc insulin
was administered i.p. to group E rats (diabetic positive
control). Rats in group C (diabetic negative control)
were left untreated.
Terminal sacrifice procedures
A mid-line incision was made through the anterior ab-
dominal walls of the rats under terminal chloroform an-
aesthesia. The liver tissues were excised and weighed.
Some of the liver tissues were fixed in in 10% formol
saline for 48 hours for histological procedures, some
fixed in Bouin’s fixative for 24 hours for histochemical
procedure while other parts were frozen for biochemical
assay.
Determination of liver weight
At sacrifice, the absolute liver weight was determined
using a top loader sensitive balance (Mettler Toledo
Germany). The relative weight of the liver (%) was
calculated from the body weight at sacrifice and the
absolute liver weights as previously described [29].
Relative weight of the liver ¼ Absolute weight
body weight at sacrifice
 100
Histological procedure
Liver tissues fixed in 10% formol saline were processed
via paraffin wax embedding method [30]. Sections of
5 μm thickness produced were stained with haematoxy-
lin and eosin (HE) for general histological examination
of the liver tissues, Gordon and Sweets reticulin stain
(GSR) [31] to histologically demonstrate reticulin fibres
in the liver and with Masson trichrome stain (MT) to
histologically demonstrate collagen fibres in liver. The
sections were examined under Leica DM750 research
microscope with a digital camera (Leica ICC50) at-
tached. Digital photomicrographs were taken at various
magnifications.
Histochemical procedure
The tissues fixed in Bouin’s fixative were processed via
paraffin wax embedding. Sections of 5 μm thickness pro-
duced were stained with periodic acid Schiff (PAS) with
diastase control to histochemically demonstrate glycogen
in the liver sections. Digital photomicrographs were also
taken after examination under Leica DM750 research
microscope
Biochemical assays
Assay for liver function markers
Blood samples were obtained from the rats by cardiac
puncture at sacrifice and were kept for 30 min at room
temperature. Serum was separated from the blood
samples by centrifugation at 5000 rpm for 10 min at
Adeyemi et al. BMC Complementary and Alternative Medicine 2014, 14:277 Page 4 of 11
http://www.biomedcentral.com/1472-6882/14/277room temperature. Serum marker of liver function
such as such as aspartate amino transferase (AST) ala-
nine amino transferase (ALT) and alkaline phosphatase
(ALP) as well as serum total proteins (TP) and albumin
(ALB) were estimated spectrophotometrically, using
enzymatic colorimetric assay kits (Randox, Northern
Ireland) following standard methods.
Preparation of tissue homogenates
The excised livers were cut into separate portions for es-
timation of catalase (CAT), superoxide dismutase (SOD),
glutathione peroxidase (GPX), glutathione (GSH) and
thiobarbituric reactive subatances (TBARS). Tissues
were rinsed in ice rinsed in ice-cold phosphate buffered
saline pH 7.4. The tissues were then homogenized at 4°C
in five volumes of homogenizing buffer per gram of
tissue using a motor driven glass-Teflon Potter-Elvejhem
homogenizer. The homogenizing buffer for CAT and
GPX assay contained 50 mM tris HCl pH 7.5, 5 mM
EDTA and 1 mM dithiotreitol (DTT); SOD assay hom-
ogenizing buffer contained 50 mM sucrose, 200 mM
mannitol and 1 mM EDTA prepared in 10 mM Tris buf-
fer pH 7.4.; GSH assay homogenizing buffer contained
50 mM potassium phosphate (PH 7.0) and 1 mM EDTA
while the homogenizing buffer for TBARS Assay was a
radio-immuno precipitation assay (RIPA) buffer which
contained 150 mM sodium chloride, 50 mM tris buffer
pH 8.0, 1.0% triton X-100, 0.1% sodium duodecyl
sulphate (SDS) and 0.5% sodium deoxycholate. The ho-
mogenates were centrifuged in Harrier 15/80 MSE ultra-
centrifuge at 13,000 rpm for 15 minutes to obtain the
supernatant.
Biochemical assay for antioxidants and lipid peroxidation
markers
The activities of CAT, SOD and GPX as well as the con-
centration of GSH and TBARS were determined in the
resulting supernatants by a 96-well microplate-based
assay using their specific quantitative colorimetric detec-
tion kits following manufacturers manual. Assay for
catalase activity was based on catalase degradation of
hydrogen peroxide using a redox dye [32]; the activity of
glutathione peroxidase was measured in the tissueTable 1 Effects of H. Sabdariffa on body weight and liver wei
Body weight (g)
A (normal control) 181.92 ± 6.49†
B (Test I) 179.75 ± 7.11†
C (Diabetic -ve control) 141.58 ± 3.33*‡
D (Test II) 168.17 ± 6.15†
E (Diabetic + ve control) 139.41 ± 2.55*‡
*p < 0.05 compared with the normal control, determined by one way ANOVA follow
†‡§within column signifies p < 0.05 between groups with different symbols, determihomogenates by measuring NADPH consumption in the
enzyme-coupled reaction [33]; the activity of SOD was
measured using sensitive colorimetric SOD assay kit
which utilizes water soluble tetrazolium salt (WST-1)
that produces a water-soluble formazan dye upon reduc-
tion with superoxide anion [34]; concentration of glutathi-
one was measured based on the reaction of 5, 5’- dithiobis
2-nitrobenzoic acid (DTNB) with reduced glutathione to
form a yellow product [35] while TBARS assay was based
on the reaction of TBARS with thiobarbituric acid (TBA)
to form a pink coloured product [36].
Statistical analysis
All values were presented as mean ± standard error of
mean (SEM) for twelve rats in each of the five group of
rats. The significance of difference in the means of all
parameters was determined using one-way analysis of
variance (ANOVA; 95% confidence interval). Dunnett
multiple comparison (DMC) and Student Newman-
Keul’s (SNK) post hoc tests were carried out for compari-
son of all groups with control and comparison of all
pairs of groups respectively. All statistics were carried
out in GraphPad Prism. Values of p < 0.05 were consid-
ered as significant [37].
Results
Acute toxicity
No sign of toxicity was observed in all groups of animals
tested within 72 hours. The LD50 of H. Sabdariffa in
Wistar rats was found to be 3200 mg kg-1.
Effects of HSCE on liver weight
The effects of HSCE on the body weight, absolute and
relative liver weight in all groups of rats are shown in
Table 1. The diabetic positive and negative controls pre-
sented with severe loss in body weight and absolute liver
weight when compared with the other groups. However
the relative weight of the liver with respect of the body
weight was essentially similar in all groups.
Effects of HSCE on liver function markers
The activities of alanine amino transferase (ALT), aspar-
tate amino transferase (AST) and alkaline phosphataseght
Absolute liver weight (g) Relative liver weight (%)
7.83 ± 0.64† 4.31 ± 0.33†
7.93 ± 0.68† 4.41 ± 0.35†
5.17 ± 0.51*‡ 3.66 ± 0.29†
7.02 ± 0.57*§ 4.17 ± 0.32†
5.08 ± 0.43*‡ 3.64 ± 0.31†
ed by DMC post hoc test.
ned by SNK post hoc test.
Table 2 Effects of H. Sabdariffa on the liver function markers
AST (U/L) ALT (U/L) ALP (U/L)
A (normal control) 11.38 ± 2.46† 10.72 ± 1.64† 85.13 ± 7.08†
B (Test I) 12.05 ± 2.36† 10.63 ± 0.33† 78.62 ± 5.28†
C (Diabetic -ve control) 45.72 ± 5.28*‡ 54.05 ± 5.03*‡ 181.94 ± 12.12*‡
D (Test II) 14.68 ± 1.64† 12.08 ± 2.42† 103.21 ± 6.98*§
E (Diabetic + ve control) 37.33 ± 5.15*§ 43.12 ± 4.16*§ 149.06 ± 9.12*ǂ
*p < 0.05 compared with the normal control, determined by one way ANOVA followed by DMC post hoc test.
†‡§ǂwithin column signifies p < 0.05 between groups with different symbols, determined by SNK post hoc test.
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trols and extract treated groups are presented in Table 2.
The activities of AST, ALT and ALP significantly in-
creased (p < 0.05) in the diabetic negative and positive
control rats when compared with the normoglycemic
rats. The activities of these liver marker enzymes were
significantly lowered in Test group II rats. However, H.
Sabdariffa had no effect on the activity of these enzymes
in normal rats.
Effects of HSCE on serum proteins
Elevated concentrations of TP and GLB in diabetic
negative control rats were brought down significantly
(p < 0.05) following administration of HSCE and insulin
(Table 3). In addition albumin – globulin ratio which
was significantly lower (p < 0.05) in the diabetic negative
control group compared with normoglycemic rats was
significantly raised in the diabetic positive control and
test group II.
Effects of HSCE on liver antioxidants
The activities of the antioxidant enzymes (catalase,
superoxide dismutase and glutathione peroxidase) and
the concentration of glutathione (a non-enzymatic anti-
oxidant) were significantly lower (p < 0.05) in the liver
of the diabetic negative control rats compared with
normoglycemic rats (Table 4). HSCE treatment elevated
the activities of these antioxidant enzymes and concen-
tration of glutathione significantly (p < 0.05) in the liver
of test group II rats better than that demonstrated by
protamin zinc insulin in the diabetic positive controlTable 3 Effects of H. Sabdariffa on the serum proteins
Total protein (g/dl) Album
A (normal control) 8.19 ± 0.36† 4.26 ±
B (Test I) 8.25 ± 0.26† 4.05 ±
C (Diabetic -ve control) 13.28 ± 0.68*‡ 4.12 ±
D (Test II) 7.95 ± 0.19† 3.86 ±
E (Diabetic + ve control) 8.21 ± 0.15† 3.93 ±
*p < 0.05 compared with the normal control, determined by one way ANOVA follow
†‡within column signifies p < 0.05 between groups with different symbols, determingroup (Table 4). However HSCE treatment had no sig-
nificant effects on these antioxidants in the liver of
normoglycemic rats.
Effects of HSCE on lipid peroxidation
The concentration of TBARS, a marker of lipid peroxi-
dation was significantly higher (p < 0.05) in the liver of
diabetic negative control rats than in normoglycemic
rats (Table 4). However HSCE treatment lowered the
level of TBARS significantly (p < 0.05) in the treated
rats.
Histopathological assessment of the liver
Examination of the stained sections of the liver of
STZ diabetic rats revealed array of pathological
changes including distortion of liver architecture,
inflammation as well as necrotic changes (Figure 1),
breakdown of reticulin fibres that formed supporting
connective tissue of the liver (Figure 2), accumula-
tion of collagen fibres in areas where reticular fibres
are broken down (Figure 3) and excessive deposition
of glycogen (Figure 4). These pathological changes
which persisted in rats treated with protamin zinc
insulin were absent in the liver section of diabetic
rats treated with HSCE. However, HSCE had no ef-
fects on the liver of normal rats.
Discussion
Diabetes mellitus is associated with progressive metabolic
derangement, worsening glycaemic control and morpho-
logical changes in the kidney, retina, liver, pancreas andin (g/dl) Globulin (g/dl) Albumin/globulin ratio
0.42† 3.93 ± 0.31† 1.08 ± 0.18†
0.18† 4.20 ± 0.26† 0.96 ± 0.21†
0.79† 9.16 ± 0.56*‡ 0.49 ± 0.06*‡
0.24† 4.09 ± 0.41† 0.95 ± 0.11†
0.65† 4.28 ± 0.12† 0.92 ± 0.13†
ed by DMC post hoc test.
ed by SNK post hoc test.
Table 4 Effects of H. Sabdariffa on the liver antioxidants and lipid peroxidation markers
CAT (U/L) GPx (U/L) SOD (U/mL) GLU (μM) TBARS (μM MDA)
A (normal control) 1.04 ± 0.07† 1.71 ± 0.06† 101.42 ± 6.11† 8.97 ± 0.71† 7.79 ± 0.72†
B (Test I) 1.09 ± 0.06† 1.67 ± 0.08† 95.04 ± 6.56† 7.78 ± 0.67† 7.12 ± 0.46†
C (Diabetic -ve control) 0.42 ± 0.04*‡ 0.86 ± 0.06*‡ 41.08 ± 3.04*‡ 3.76 ± 0.38*‡ 17.56 ± 1.02*§
D (Test II) 0.72 ± 0.06*§ 1.37 ± 0.06*§ 87.92 ± 5.26§ 6.87 ± 0.51† 8.63 ± 0.65†
E (Diabetic + ve control) 0.37 ± 0.03*‡ 0.97 ± 0.05*‡ 46.58 ± 3.57*‡ 3.26 ± 0.39*‡ 11.56 ± 0.73*ǂ
*p < 0.05 compared with the normal control, determined by one way ANOVA followed by DMC post hoc test.
†‡§ǂwithin column signifies p < 0.05 between groups with different symbols, determined by SNK post hoc test.
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a significant role in the induction of these processes
[40]. A number of studies both in vitro and in vivo had
shown that extracts of the calyx of H. sabdariffa has
potent antioxidant activity [41,42]. This potent antioxida-
tion is thought to form the basis of many of the other
healing activities of HSCE including its hepatoprotectiveFigure 1 Photomicrographs showing the liver of the experimental rat
control, D – test group II and E – diabetic positive control) stained wi
central vein (CV) with sinusoids (arrow) in between the plates. Architecture
and signs of inflammation were observed in group C liver while group E liv
poorly defined hepatocytes and sinusoids except those in the immediate v
also observed in the liver of group C and E rats.activities. Compounds proven to have this antioxi-
dant activity include anthocyanins and protocatechuic
acid [43].
The results of this study showed a significant increase
in lipid peroxidation in the liver of STZ diabetic rats.
This confirms the earlier report on the ability of this dia-
betogenic compound to induce oxidative damage throughs (A - normoglycaemic rats, B – test group I, C – diabetic negative
th H & E. Note the hepatocytes (H) arranged in plates around the
of groups A B and D liver appeared normal. Distortion of architecture
er section revealed a disheveled pattern of liver architecture with
icinity of the central vein. Vascular congestion of the central vein was
Figure 2 Photomicrographs showing the liver of the experimental rats (A - normoglycaemic rats, B – test group I, C – diabetic negative
control, D – test group II and E – diabetic positive control) stained with Gordon and Sweets reticulin stain. Note the reticular fibres
(stained black) lining the sinusoids (arrow) where they are between plates of liver cells (stained yellow) and also form a dense network (star)
around the central vein (CV). The reticular fibres are well stained in the liver section of groups A, B and D rats. However, in groups C and E liver,
the reticular fibres are poorly stained except where they form dense network around the central vein.
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peroxidation in the liver may be due to the fact that it
contains relatively high concentration of easily peroxi-
dizable fatty acid. Administration of methanolic extract
of H. sabdariffa reduced MDA, a marker of lipid per-
oxidation in the liver of diabetic rats suggesting that
the extract possesses potent antioxidative properties.
The present results are consistent with the report of
previous researchers who earlier reported antioxidant
effect of extracts from H. sabdariffa [41].
In this study, a marked decrease in the activities of
catalase (CAT), superoxide dismutase (SOD) and gluta-
thione peroxidase (GPx) in the liver of untreated diabetic
rats were observed. The functions of these antioxidant
enzymes are interconnected and a decrease of their ac-
tivities results in the accumulation of lipid peroxides and
increases oxidative stress in diabetic rats [45]. Treatment
of rats with extracts of H. sabdariffa ameliorated the
STZ-induced decrease in the concentration of GSH aswell as the activities of GPx, SOD and CAT. The results,
therefore, lend support to the antioxidant properties of
H. sabdariffa as demonstrated in both in vitro and vari-
ous in vivo models [41,46].
Hepatic cellular degeneration, degeneration of reticular
fibres as shown in the silver impregnated liver section
(Figure 2) and build up of collagen fibres as shown in
the liver sections stained for presence of collagen
(Figure 3) revealed the presence of hepatic fibrosis in
the liver of STZ-diabetic rats and the insulin treated
diabetic rats. The PAS stained sections also revealed
an excessive accumulation of glycogen in the liver of
the diabetic rats (Figure 4). However, there was
restoration of the normal liver morphology in the H.
sabdariffa – treated diabetic rats. This was shown by
a regeneration of reticular fibres as well as reduction
in the collagen staining in the liver section of the
extract-treated rats. Also, PAS – stained liver section
of this group of rats’ reveled glycogen staining that is
Figure 3 Photomicrographs showing the liver of the experimental rats (A - normoglycaemic rats, B – test group I, C – diabetic negative
control, D – test group II and E – diabetic positive control) stained with Masson trichrome stain. Note extensive area of collagen staining
(black star) around the CV as well as the intercellular matrix around the hepatocytes of the liver groups C and E rats.
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logical evaluation of the liver of these rats also revealed
that H. sabdariffa extract also reduced the incidence of
liver lesions, including hepatocyte swelling and necrosis
induced by STZ.
Hepatic fibrosis is present in various chronic hepatic
diseases. It is well known that constant fibrosis can lead
to the development of hepatocellular carcinoma [47,48].
Interrupting and/or reversing hepatic fibrosis may well
be a new approach for improving its progression to
hepatocellular carcinoma. However, the therapy for
reversing liver fibrosis is not yet well established. This
study demonstrated that H. sabdariffa extract had
therapeutic effects on hepatic fibrosis secondary to
diabetes induced by STZ in rats. The beneficial effects
of H. sabdariffa extract in the treatment of chemically-
induced fibrosis were evident in liver pathology, as
evidenced by decreased severity of the liver morpho-
logical changes and fibrosis, generalized improvement
of some types of pathological lesions such as fatty
liver and cellular degeneration, and reduced hepaticcollagen fiber staining. These ameliorative effects of
H. sabdariffa extract may be mediated by inhibition
of hepatic stellate cell activation. In accord with the
preventive effects of H. sabdariffa extract’s compo-
nents during the development of chemically induced
hepatic damage [20,21,43,49] the present study shows
that H. sabdariffa extract is effective in the amelior-
ation of STZ-induced liver fibrosis, which would
confer a highly significant therapeutic advantage. Hi-
biscus sabdariffa extract is a composite of several
antioxidants, such as protocatechuic acid [20,50] and
anthocyanins [21,22] which prevents peroxidative liver
damage.
The activities of AST, ALT and APL increased sig-
nificantly in diabetic rats in agreement with previous
findings [51]. The extract of H sabdariffa significantly
reduced the activities of AST and ALT in these rats.
This finding is consistent with the finding of Ubani et al.
[52] who earlier reported that extract of H. sabdariffa
lowered the activities of these liver marker enzymes in
phenobarbitone induced rats.
Figure 4 Photomicrographs showing the liver of the experimental rats (A- normoglycaemic rats, B- test group I, C-diabetic negative control, D
test group II, E-diabetic positive control) stained with PAS (arrow) with diastase control (star). The liver section of group C was deeply stained with
PAS while liver sections of other groups were moderately stained with PAS. Diastase negative control was negative to PAS staining in all groups.
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In conclusion, this study demonstrated the poten-
tials of Hibiscus sabdariffa extract in ameliorating
the biochemical and histological changes in the liver
of Wistar rats following experimental induction ofdiabetes mellitus in these rats using STZ. The
ameliorative activity of Hibiscus sabdariffa extract in
the liver of STZ diabetic rats could be partly re-
lated to its antioxidant activity and the presence of
flavonnoids.
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